Quotient Wealth Partners’s Boston Scientific BSX Stock Holding History

Quotient Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,929	Closed	-$309K	–	415
2026 Q1	$309K	Sell	4,929 -966	-16%	-$77.3K	0.01%	277
2025 Q4	$562K	Sell	5,895 -356	-6%	-$34.9K	0.02%	175
2025 Q3	$610K	Buy	6,251 +287	+5%	+$29.7K	0.02%	166
2025 Q2	$641K	Buy	5,964 +543	+10%	+$54.9K	0.02%	157
2025 Q1	$547K	Buy	5,421 +376	+7%	+$37.9K	0.02%	166
2024 Q4	$451K	Buy	5,045 +285	+6%	+$25.1K	0.01%	189
2024 Q3	$399K	Buy	4,760 +71	+2%	+$5.6K	0.01%	204
2024 Q2	$361K	Buy	4,689 +553	+13%	+$40.5K	0.01%	218
2024 Q1	$283K	Buy	4,136 +578	+16%	+$37.2K	0.01%	238
2023 Q4	$206K	Buy	+3,558	New	+$190K	0.01%	270

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Quotient Wealth Partners's BSX Position: Q2 2026 in Review

Quotient Wealth Partners sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,929 shares — an estimated $309K sold.

Quotient Wealth Partners first reported a position in BSX in Q4 2023 and held it in 10 quarters. The position peaked at $641K in Q2 2025. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Quotient Wealth Partners reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Quotient Wealth Partners sold 4,929 Boston Scientific shares in Q2 2026, an estimated $309K.
Quotient Wealth Partners first reported a position in Boston Scientific in Q4 2023 and held it in 10 quarters.
Quotient Wealth Partners's Boston Scientific position peaked at $641K in Q2 2025.
1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Quotient Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.